Juan C. Jaén

C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN

Hong Xiao, Daniel J. Dairaghi, Jay P. Powers et al. · Journal of the American Society of Nephrology · 2013 · 356 citations

Life Sciences, Immunology, Pathobiology +17

Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands

Brian A. Zabel, Yu Wang, Susanna Lewén et al. · The Journal of Immunology · 2009 · 288 citations · Full text

Life Sciences, Oncology, Pharmacology +15

4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties

Juan C. Jaén, Lawrence D. Wise, Bradley W. Caprathe et al. · Journal of Medicinal Chemistry · 1990 · 255 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Selective, covalent modification of β-tubulin residue Cys-239 by T138067, an antitumor agent with <i>in vivo</i> efficacy against multidrug-resistant tumors

Bei Shan, Julio C. Medina, Edit Santha et al. · Proceedings of the National Academy of Sciences · 1999 · 163 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease

Matthew J. Walters, Yu Wang, Trageen Baumgart et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 159 citations

Life Sciences, Immunology, Pharmacology +17